ClinVar Genomic variation as it relates to human health
NM_001492.6(GDF1):c.681C>A (p.Cys227Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001492.6(GDF1):c.681C>A (p.Cys227Ter)
Variation ID: 6747 Accession: VCV000006747.31
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 19p13.11 19: 18869035 (GRCh38) [ NCBI UCSC ] 19: 18979844 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 8, 2017 Oct 20, 2024 Mar 1, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001492.6:c.681C>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001483.3:p.Cys227Ter nonsense NM_021267.5:c.*950C>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
3 prime UTR NM_001387438.1:c.681C>A NP_001374367.1:p.Cys227Ter nonsense NM_001387440.1:c.*1542C>A 3 prime UTR NC_000019.10:g.18869035G>T NC_000019.9:g.18979844G>T NG_012070.1:g.32110C>A NG_033056.1:g.32110C>A - Protein change
- C227*
- Other names
- -
- Canonical SPDI
- NC_000019.10:18869034:G:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00050
The Genome Aggregation Database (gnomAD) 0.00058
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
CERS1 | - | - |
GRCh38 GRCh37 |
- | 470 | |
GDF1 | - | - |
GRCh38 GRCh37 |
2 | 472 | |
UPF1 | - | - |
GRCh38 GRCh37 |
83 | 96 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
criteria provided, single submitter
|
Oct 19, 2020 | RCV000007139.15 | |
Pathogenic/Likely pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Nov 20, 2023 | RCV000055615.16 | |
Pathogenic/Likely pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Mar 1, 2024 | RCV000417815.29 | |
GDF1-RELATED DISORDERS
|
Likely pathogenic (1) |
criteria provided, single submitter
|
- | RCV003335019.1 |
GDF1-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Jun 21, 2024 | RCV003407289.6 |
Pathogenic (1) |
no assertion criteria provided
|
Jul 15, 2010 | RCV004576881.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Oct 06, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Right atrial isomerism
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV003835748.1
First in ClinVar: Mar 11, 2023 Last updated: Mar 11, 2023 |
|
|
Likely pathogenic
(Nov 22, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV003832998.2
First in ClinVar: Mar 04, 2023 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Dec 06, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000253705.9
First in ClinVar: Oct 11, 2015 Last updated: Feb 28, 2024 |
Comment:
This sequence change creates a premature translational stop signal (p.Cys227*) in the GDF1 gene. While this is not anticipated to result in nonsense mediated decay, … (more)
This sequence change creates a premature translational stop signal (p.Cys227*) in the GDF1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 146 amino acid(s) of the GDF1 protein. This variant is present in population databases (rs121434422, gnomAD 0.09%). This premature translational stop signal has been observed in individual(s) with heterotaxy syndrome (PMID: 20413652). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6747). This variant disrupts the p.Cys277 amino acid residue in GDF1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17924340, 17936261, 20413652). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Oct 19, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Congenital heart defects, multiple types, 6
(Autosomal recessive inheritance)
Affected status: unknown
Allele origin:
germline
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV002767545.1
First in ClinVar: Dec 24, 2022 Last updated: Dec 24, 2022 |
Comment:
Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as 5-pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism … (more)
Based on the classification scheme VCGS_Germline_v1.3.3, this variant is classified as 5-pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with right atrial isomerism (MIM#208530). Although loss of function has been demonstrated for missense variants, there is currently limited evidence demonstrating loss of function for truncating variants (PMIDs: 1792434; 20413652). (I) 0106 - This gene is associated with autosomal recessive disease. This gene has also been associated right atrial isomerism (Ivemark) (RAI) (MIM#208530) and congenital heart defects, multiple types, 6 (MIM#613854) (OMIM; PMID: 28991257) (I) 0204 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with at least 1/3 of the protein sequence affected. This variant might also affect the production of active protein although there is currently no functional evidence demonstrating this (PMID: 1792434; 20413652). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (13 heterozygotes, 0 homozygotes). (SP) 0702 - Other protein truncating variants comparable to the one identified in this case have strong previous evidence for pathogenicity. There are two protein truncating variants downstream of our variant of interest (ClinVar, Decipher). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been identified in 4 unrelated individuals with right atrial isomerism (MIM#208530) and a single patient with congenital heart defect (MIM#613854) (ClinVar, PMIDs: 1792434, 20413652, 32144877). (SP) 0901 - This variant has strong evidence for segregation with disease. This variant has been shown to segregate with disease in one family with five individuals diagnosed with right atrial isomerism (MIM#208530) (PMID: 20413652). (SP) 1007 - No published functional evidence has been identified for this variant. (I) 1101 - Very strong and specific phenotype match for this individual's fetus. (SP) 1201 - Heterozygous variant detected in trans with a second pathogenic heterozygous variant (c.1047_1050delCTTT; p.(Phe349Leufs*35)) in a recessive disease (reported by Invitae #RQ1502139). (SP) 1205 - This variant has been shown to be paternally inherited in the fetus with symptoms consistent with congenital heart defects or heterotaxy (reported by Invitae #RQ1502139). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign (less)
|
|
Pathogenic
(Sep 27, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000513132.10
First in ClinVar: Mar 08, 2017 Last updated: Oct 05, 2023 |
Comment:
Nonsense variant predicted to result in protein truncation, as the last 146 amino acids are lost, and other loss-of-function variants have been reported downstream in … (more)
Nonsense variant predicted to result in protein truncation, as the last 146 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 29429572, 32144877, 30679813, 34313030, 26258520, 18375573, 20497191, 19553149, 14648004, 20413652, 28991257, 34328347, 17924340) (less)
|
|
Likely pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
GDF1-RELATED DISORDERS
Affected status: yes
Allele origin:
germline
|
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
Accession: SCV004046051.1
First in ClinVar: Oct 21, 2023 Last updated: Oct 21, 2023 |
Comment:
This nonsense variant is found in the last exon of GDF1 and is therefore predicted to escape nonsense-mediated mRNA decay (NMD). This variant has been … (more)
This nonsense variant is found in the last exon of GDF1 and is therefore predicted to escape nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a heterozygous change in an individual with transposition of the great arteries (PMID: 17924340), and as a compound heterozygous change in patients with cardiac defects (PMID: 20413652, 28991257), including five siblings with right atrial isomerism, who harbored a frameshift variant on the opposite GDF1 allele; the parent who was heterozygous for the p.Cys227Ter variant was unaffected (PMID: 20413652). Heterozygous loss-of-function mutations in GDF1 are a known mechanism of cardiac defects ranging from tetralogy of Fallot to transposition of the great arteries (PMID: 17924340, 28991257, 23410880). The c.681C>A (p.Cys227Ter) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.05% (13/25686) and thus is presumed to be rare. Based on the available evidence, the c.681C>A (p.Cys227Ter) variant is classified as Likely Pathogenic. (less)
|
|
Likely pathogenic
(Nov 20, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Right atrial isomerism
Affected status: yes
Allele origin:
paternal
|
Institute of Human Genetics, Heidelberg University
Accession: SCV004814192.1
First in ClinVar: Apr 20, 2024 Last updated: Apr 20, 2024 |
Sex: female
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Right atrial isomerism
Affected status: yes
Allele origin:
germline
|
Institute of Human Genetics, Medical University Innsbruck
Accession: SCV005044710.1
First in ClinVar: May 26, 2024 Last updated: May 26, 2024 |
|
|
Pathogenic
(Mar 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004145276.10
First in ClinVar: Nov 20, 2023 Last updated: Oct 20, 2024 |
Comment:
GDF1: PVS1:Strong, PM1, PM2, PM3
Number of individuals with the variant: 2
|
|
Pathogenic
(Jul 15, 2010)
|
no assertion criteria provided
Method: literature only
|
TRANSPOSITION OF THE GREAT ARTERIES
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000027335.5
First in ClinVar: Apr 04, 2013 Last updated: Dec 15, 2018 |
Comment on evidence:
Transposition of the Great Arteries In a patient with transposition of the great arteries (CHDT6; 613854), Karkera et al. (2007) found heterozygous substitution of a … (more)
Transposition of the Great Arteries In a patient with transposition of the great arteries (CHDT6; 613854), Karkera et al. (2007) found heterozygous substitution of a stop codon for cys227 of the GDF1 proprotein (C227X). The mutation was considered a likely loss-of-function change because of premature termination in the prodomain. Right Atrial Isomerism In 5 affected sibs in a Finnish family with right atrial isomerism (RAI; 208530), originally reported by Eronen et al. (2004), Kaasinen et al. (2010) compound heterozygosity for mutations in the GDF1 gene: a c.681C-A transversion in exon 8, resulting in the C22X substitution, and a 1-bp insertion in exon 8 (c.909insC; 602880.0004), causing a frameshift predicted to result in a severely altered protein and premature termination. Their unaffected parents were each heterozygous for 1 of the mutations. In a patient (1-05386) with right isomerism, Jin et al. (2017) identified compound heterozygosity for the C22X mutation and a 3-bp deletion (c.1090_1092delATG) in the GDF1 gene, resulting in deletion of the Met364 residue (Met364del; 602880.0005). The patient exhibited abdominal heterotaxy as well as multiple cardiac anomalies, including dextrocardia, double-outlet right ventricle, obstructed total anomalous pulmonary venous return, valvular and subvalvular pulmonary stenosis, persistent left superior vena cava, right-dominant atrioventricular canal, common atrium, and single ventricle. (less)
|
|
Pathogenic
(Jul 15, 2010)
|
no assertion criteria provided
Method: literature only
|
RIGHT ATRIAL ISOMERISM
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000083840.4
First in ClinVar: Sep 26, 2013 Last updated: Dec 15, 2018 |
Comment on evidence:
Transposition of the Great Arteries In a patient with transposition of the great arteries (CHDT6; 613854), Karkera et al. (2007) found heterozygous substitution of a … (more)
Transposition of the Great Arteries In a patient with transposition of the great arteries (CHDT6; 613854), Karkera et al. (2007) found heterozygous substitution of a stop codon for cys227 of the GDF1 proprotein (C227X). The mutation was considered a likely loss-of-function change because of premature termination in the prodomain. Right Atrial Isomerism In 5 affected sibs in a Finnish family with right atrial isomerism (RAI; 208530), originally reported by Eronen et al. (2004), Kaasinen et al. (2010) compound heterozygosity for mutations in the GDF1 gene: a c.681C-A transversion in exon 8, resulting in the C22X substitution, and a 1-bp insertion in exon 8 (c.909insC; 602880.0004), causing a frameshift predicted to result in a severely altered protein and premature termination. Their unaffected parents were each heterozygous for 1 of the mutations. In a patient (1-05386) with right isomerism, Jin et al. (2017) identified compound heterozygosity for the C22X mutation and a 3-bp deletion (c.1090_1092delATG) in the GDF1 gene, resulting in deletion of the Met364 residue (Met364del; 602880.0005). The patient exhibited abdominal heterotaxy as well as multiple cardiac anomalies, including dextrocardia, double-outlet right ventricle, obstructed total anomalous pulmonary venous return, valvular and subvalvular pulmonary stenosis, persistent left superior vena cava, right-dominant atrioventricular canal, common atrium, and single ventricle. (less)
|
|
Pathogenic
(Jun 21, 2024)
|
no assertion criteria provided
Method: clinical testing
|
GDF1-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004106981.3
First in ClinVar: Nov 20, 2023 Last updated: Oct 08, 2024 |
Comment:
The GDF1 c.681C>A variant is predicted to result in premature protein termination (p.Cys227*). This variant has previously been reported in the heterozygous state in an … (more)
The GDF1 c.681C>A variant is predicted to result in premature protein termination (p.Cys227*). This variant has previously been reported in the heterozygous state in an individual with transposition of the great arteries (Kakera et al. 2007. PubMed ID: 17924340). This variant was also reported in an individual with conotruncal defects. The variant was inherited; however, the phenotype of the parents was not provided (Patient 1-05514 - Table S1/S7 - Jin et al. 2017. PubMed ID: 28991257). In the compound heterozygous state this variant was found in five siblings with right atrial isomerism (Kaasinen et al. 2010. PubMed ID: 20413652) and an individual with heterotaxy (Patient 1-05386 - Table S1/S3 - Jin et al. 2017. PubMed ID: 28991257). The parents of the five siblings with right atrial isomerism were reported to be unaffected (Kaasinen et al. 2010. PubMed ID: 20413652). Of note, this variant is in 13 out of 25,686 alleles (~0.05%) in the gnomAD database; however, this may not be accurate due to low sequence coverage in this region. Nonsense variants in GDF1 are expected to be pathogenic for autosomal recessive disease; however, their role in autosomal dominant disease is uncertain. This variant is interpreted as pathogenic. (less)
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A founder truncating variant in GDF1 causes autosomal-recessive right isomerism and associated congenital heart defects in multiplex Arab kindreds. | Marek-Yagel D | American journal of medical genetics. Part A | 2020 | PMID: 32144877 |
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. | Jin SC | Nature genetics | 2017 | PMID: 28991257 |
Recessively inherited right atrial isomerism caused by mutations in growth/differentiation factor 1 (GDF1). | Kaasinen E | Human molecular genetics | 2010 | PMID: 20413652 |
Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development. | Andersson O | Developmental biology | 2007 | PMID: 17936261 |
Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans. | Karkera JD | American journal of human genetics | 2007 | PMID: 17924340 |
Right atrial isomerism in four siblings. | Eronen M | Pediatric cardiology | 2004 | PMID: 14648004 |
[Lung transplantation]. | Caubarrère I | La Revue de medecine interne | 1991 | PMID: 1792434 |
Text-mined citations for rs121434422 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.